Kimiaki Takagi
11PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jun 26, 2024
Impact of Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.Naotaka Kumada, Koji Iinuma, Yasuaki Kubota
|Feb 11, 2023
The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study.Koji Iinuma, Toyohiro Yamada, Koji Kameyama
|Nov 10, 2022
CALN1 hypomethylation as a biomarker for high-risk bladder cancer.Kimiaki Takagi, Azumi Naruse, Kazutoshi Akita
|Oct 14, 2022
Effectiveness and Safety of Molecular-Targeted Therapy after Nivolumab Plus Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study.Koji Iinuma, Koji Kameyama, Tomoki Taniguchi
|Sep 23, 2022
Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort Study.Toyohiro Yamada, Keita Nakane, Torai Enomoto
|Aug 25, 2022
Clinical Lymph Node Involvement as a Predictor for Cancer-Specific Survival in Patients with Penile Squamous Cell Cancer.Makoto Kawase, Kimiaki Takagi, Kei Kawada
Pageof 2
